Millie
your market intelligence analyst
Search Results
17,410 results
Your search is now limited to «Diabetes in the News» expert search.
Jerusalem Post (Israel) 10/21/2019 16:06
Breastfeeding tied to lower risk of diabetes, high blood pressure - HEALTH & SCIENCE.
More from Jerusalem Post (Israel):
American Diabetes Journals 10/21/2019 15:00
At the other end of the spectrum, long-standing diabetes may require insulin treatment if β-cell deficiency is advanced.
More from American Diabetes Journals:
Healio News 10/21/2019 14:46
Adults with diabetes have increased risks for infections, such as influenza, cellulitis and sepsis, compared with adults without diabetes, according to findings published in Diabetes Care.
More from Healio News:
Montreal Canadiens’ star Max Domi will share his inspiring journey to the NHL after being diagnosed with type 1 diabetes in his new memoir.
More from Diabetes Self-Management - blog:
DoctorsLounge 10/21/2019 13:00
Adjuvant cyclical pressure TWO2 therapy better than sham control therapy for chronic diabetic foot ulcers.
More from DoctorsLounge:
Aerztezeitung (Germany) 10/21/2019 10:59
Der Gemeinsame Bundesausschuss (GBA) spricht dem SGLT2-Hemmer Dapagliflozin (Forxiga® 5 mg) einen Zusatznutzen bei der Therapie von Erwachsenen mit Typ-1-Diabetes zu, teilt das Unternehmen AstraZeneca mit.
More from Aerztezeitung (Germany):
In traditional diabetes management, patients check their blood sugar levels several times per day, including before and after meals, and administer insulin via injection or with a wearable insulin pump.
More from Stanford School of Medicine - Scope Blog:
Graumlich et al evaluated MedTable, a patient education tool embedded within the EHR, which promoted medication review and reconciliation between patients and providers in a randomized controlled trial among 674 patients with type 2 diabetes.
More from Journal of Medical Internet Research:
FeedNavigator (EU) 10/21/2019 09:21
This is promising news for the 30 million people living with type-2 diabetes in the United States, as heart failure is one of the earliest cardiovascular complications for them, before heart attack or stroke," Ruud Dobber, executive vice president of BioPharmaceuticals at AstraZeneca, said in the company statement.
More from FeedNavigator (EU):
ENDPOINTS 10/21/2019 08:55
Late last month, the FDA expanded Invokana’s label to slow the progression of diabetic nephropathy (DKD), as well as to reduce the risk of hospitalization for heart failure in patients with type II diabetes and DKD — an indication that no other type II diabetes medicine is approved for.
More from ENDPOINTS:
NHS England (UK) 10/21/2019 07:43
Nearly 30,000 people across the country with Type 1 diabetes have received life-changing diabetes monitors through the NHS Long Term Plan.
More from NHS England (UK):
Business Wire 10/21/2019 07:00
Ruud Dobber, Executive Vice President, BioPharmaceuticals Business Unit, said: “FARXIGA is the first SGLT2 inhibitor approved in the US to reduce the risk of hospitalization for heart failure in type 2 diabetes patients with established cardiovascular disease or multiple cardiovascular risk factors.
More from Business Wire:
GlobeNewswire 10/21/2019 06:45
Under his leadership, our business introduced the world’s first hybrid closed-loop insulin pump system – the MiniMed® 670G System – and increased Diabetes Group revenue by over $700 million.
More from GlobeNewswire:
PharmaTimes 10/21/2019 06:22
The excellence of those working in diabetes care was celebrated at last week’s annual Quality in Care Diabetes awards, held at Sanofi UK’s new head office in Reading.
More from PharmaTimes:
NaturalNews.com 10/21/2019 05:42
Diabetes has two forms: Type 1 diabetes, also known as juvenile diabetes, is a result of the pancreas producing very little insulin.
More from NaturalNews.com:
It found that when monounsaturated fats are high in a weight loss diet, the insulin sensitivity of the patient also improves.
More from International Business Times (United Kingdom):
ETHealthWorld (India) 10/21/2019 03:07
The approval by the U.S. Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial, the British drugmaker said and follows a similar approval by the European authorities in August.
More from ETHealthWorld (India):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications